Horizon Pharma Plc engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat arthritis, inflammation, and orphan diseases. It distributes under the following brands: Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos, and Vimovo. The company was founded on December 20, 2011 and is headquartered in Dublin, Ireland.
No unusual activity trades found. Try filtering by a different expiration or removing any global filters.